Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 2
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Su, Pai-Wei Yang, Cheng-Hong Yang, Jyh-Ferng Su, Pei-Yu and Chuang, Li-Yeh 2015. Antibacterial Activities and Antibacterial Mechanism of Polygonum cuspidatum Extracts against Nosocomial Drug-Resistant Pathogens. Molecules, Vol. 20, Issue. 6, p. 11119.


    Piso, Rein Jan Pop, R. Wieland, M. Griesshammer, I. Urfer, M. Schibli, U. and Bassetti, S. 2016. Low sensitivity of needle aspiration cultures in patients with cellulitis/erysipelas. SpringerPlus, Vol. 5, Issue. 1,


    ×

Antimicrobial resistance in eight US hospitals along the US–Mexico border, 2000–2006

  • S. R. BENOIT (a1), K. D. ELLINGSON (a1), S. H. WATERMAN (a2) and M. L. PEARSON (a3)
  • DOI: http://dx.doi.org/10.1017/S095026881300318X
  • Published online: 17 December 2013
Abstract
SUMMARY

Antimicrobial resistance (AR) is a growing problem worldwide and international travel, cross-border migration, and antimicrobial use may contribute to the introduction or emergence of AR. We examined AR rates and trends along the US–Mexico border by analysing microbiology data from eight US hospitals in three states bordering Mexico. Microbiology data were ascertained for the years 2000–2006 and for select healthcare and community pathogens including, three Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae) and three Gram-positive (Staphylococcus aureus, Enterococcus, Streptococcus pneumoniae) pathogens and 10 antimicrobial–pathogen combinations. Resistance was highest in S. aureus (oxacillin resistance 45·7%), P. aeruginosa (quinolone resistance 22·3%), and E. coli (quinolone resistance 15·6%); six (60%) of the 10 antimicrobial–pathogen combinations studied had a significantly increasing trend in resistance over the study period. Potential contributing factors in the hospital and community such as infection control practices and antimicrobial use (prescription and non-prescription) should be explored further in the US–Mexico border region.

Copyright
Corresponding author
*Author for correspondence: S. R. Benoit, MD, MPH, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS E-03, Atlanta, GA 30333, USA. (Email: bvy8@cdc.gov)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.


2.SE Cosgrove . Evidence that prevention makes cents: costs of catheter-associated bloodstream infections in the intensive care unit. Critical Care Medicine 2006; 34: 22432244.

3. RMKlevens , Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clinical Infectious Diseases 2006; 42: 389391.

6.BA Rogers , Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clinical Infectious Diseases 2011; 53: 4956.

9. TJDoyle , RTBryan . Infectious disease morbidity in the US region bordering Mexico, 1990–1998. Journal of Infectious Diseases 2000; 182: 15031510.

10. TLByrd , JGLaw . Cross-border utilization of health care services by United States residents living near the Mexican border. Revista Panamericana de Salud Publica 2009; 26: 95100.

11.GC de Guzman , A survey of the use of foreign-purchased medications in a border community emergency department patient population. Journal of Emergency Medicine 2007; 33: 213221.

13. JORivera , Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border. Travel Medicine and Infectious Disease 2009; 7: 3034.

14.FG O'Brien , Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas. Journal of Clinical Microbiology 2005; 43: 29692972.

15.M Weinberg , The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance. Emerging Infectious Diseases 2003; 9: 97102.

17.GV Sanchez , In Vitro Antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents and Chemotherapy 2012; 56: 21812183.

18. LJohnson , Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. American Journal of Medicine 2008; 121: 876884.

19.National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 2004; 32: 470485.

21.SK Fridkin , Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 14361444.

22.AL Hersh , National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Archives of Internal Medicine 2008; 168: 15851591.

23.U Seybold , Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647656.

24. DCBurton , Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. Journal of the American Medical Association 2009; 301: 727736.

26.DJ Diekema , Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clinical Infectious Diseases 2004; 38: 7885.


28.MH Kyaw , Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine 2006; 354: 14551463.

29. BWBeall , Shifting genetic structure of invasive serotype 19A pneumococci in the United States. Journal of Infectious Diseases 2011; 203: 13601368.

30.AC Nyquist , Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. Journal of the American Medical Association 1998; 279: 875877.

31. IPeláez-Ballestas , Use of antibiotics in upper respiratory infections on patients under 16 years old in private ambulatory medicine. Salud Publica de Mexico 2003; 45: 159164.

32. AJKallen , HGWelch , BESirovich . Current antibiotic therapy for isolated urinary tract infections in women. Archives of Internal Medicine 2006; 166: 635639.

33.C Gagliotti , Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. Clinical Microbiology and Infection 2007; 13: 328331.

34.AN Ortega , Health care access, use of services, and experiences among undocumented Mexicans and other Latinos. Archives of Internal Medicine 2007; 167: 23542360.

35.D Yong , Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy 2009; 53: 50465054.

38.A Dreser , Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health 2012; 12: 1051.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
UNKNOWN
Supplementary Materials

Benoit et al. Supplementary Material
Tables

 Unknown (91 KB)
91 KB